黄芩素通过抑制铁死亡与内质网应激减轻大鼠心脏骤停模型脑损伤
该研究在Sprague-Dawley大鼠上建立心脏骤停-心肺复苏模型,将存活大鼠随机分为五组(每组n=6),分别给予铁死亡抑制剂和内质网应激激动剂单独或联合干预,另设无药物干预组,假手术组(n=6)不诱导心室颤动。结果显示,与CPR组相比,黄芩素治疗改善神经功能结局并减少神经细胞损伤,脑组织ALOX15降低、线粒体形态结构更好,内质网应激标志物GRP78、ATF4和CHOP降低。ROS检测显示,衣霉素组ROS高于CPR组,黄芩素+衣霉素组ROS低于衣霉素组。作者结论认为铁死亡和内质网应激均参与复苏后脑损伤,黄芩素通过抑制二者减轻脑损伤,部分通过抑制内质网应激减少ROS。
要点
- 在大鼠心脏骤停-心肺复苏模型中,与CPR组相比,黄芩素治疗改善神经功能结局并减少神经细胞损伤。
- 复苏后脑组织中观察到铁死亡相关改变,包括铁含量、GPX4、ROS、ALOX15及线粒体特征的变化。
- 黄芩素组ALOX15低于CPR组,线粒体形态结构优于CPR组。
- 黄芩素组内质网应激标志物GRP78、ATF4和CHOP低于CPR组;衣霉素组ROS高于CPR组,黄芩素+衣霉素组ROS低于衣霉素组。
- 作者认为铁死亡和内质网应激均参与复苏后脑损伤,黄芩素是减轻复苏后脑损伤的潜在药物。
适用人群与场景
- Sprague-Dawley大鼠心脏骤停-心肺复苏模型;假手术组(n=6)不诱导心室颤动至心脏骤停及心肺复苏,存活大鼠随机分为五组(每组n=6)。
处置流程与药物剂量
- 三个组分别单独及联合给予铁死亡抑制剂和内质网应激激动剂,另一组无药物干预;黄芩素为铁死亡抑制剂。
- 以2',7'-二氯荧光素二乙酸酯作为氧化荧光探针检测脑ROS生成。
- 采用Western blot测定铁死亡和内质网应激相关蛋白;记录神经功能缺损评分。
研究设计与关键结果
- 研究类型为大鼠心脏骤停模型实验;假手术组n=6,存活大鼠随机分为五组(每组n=6)。
- 与CPR组相比,黄芩素治疗改善神经功能结局并减少神经细胞损伤。
- 复苏后脑组织观察到铁死亡改变:铁含量、GPX4、ROS、ALOX15及线粒体特征发生变化;黄芩素组ALOX15低于CPR组。
- 黄芩素组线粒体形态和结构优于CPR组。
- 黄芩素组内质网应激标志物GRP78、ATF4和CHOP低于CPR组。
- 衣霉素组ROS高于CPR组;黄芩素+衣霉素组ROS低于衣霉素组。
证据类型、等级与局限
- 证据类型:大鼠心脏骤停模型实验(动物实验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为铁死亡和内质网应激均参与复苏后脑损伤,黄芩素通过抑制铁死亡和内质网应激减轻脑损伤,并部分通过抑制内质网应激减少ROS。
- 作者认为黄芩素是减轻复苏后脑损伤的潜在药物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Cardiac arrest (CA) is one of the leading causes of death worldwide. Endoplasmic reticulum (ER) stress and ferroptosis are proven pathological mechanisms implicated in neuronal damage. Baicalein, a ferroptosis Inhibitor, improved outcomes after traumatic brain injury. We aimed to explore the effects of baicalein on brain injury via ferroptosis and ER stress in a rat model of CA.Methods: Cardiac arrest models were established in Sprague-Dawley (SD) rats. The sham group (n = 6) was untreated with inducing ventricular fibrillation to cardiac arrest and cardiopulmonary resuscitation (CPR). Survival rats were randomly divided into five groups (n = 6). Ferroptosis inhibitor and ER stress agonist were administered separately and together in three groups. There was no drug intervention in the remaining group. The neurological deficit scores were recorded. Characteristics of ferroptosis were observed. And the associated protein of ferroptosis and ER stress were determined by Western blot. Cerebral ROS production was measured by using 2',7'-dichlorofluorescein diacetate as the oxidative fluorescent probe. Results: Baicalein treatment improved neurological outcomes and decreased neurocyte injuries compared with CPR group. The changes of ferroptosis, more specifically, iron content, glutathione peroxidase 4 (GPX4), reactive oxygen species (ROS), arachidonate 15-lipoxygenase (ALOX15) and mitochondrial characteristics, were observed in brain tissue after ROSC. ALOX15 was lower in baicalein group than in CPR group. The morphology and structure of mitochondria in baicalein group were better than in CPR group. The ER stress markers, glucose-regulated protein 78, activating Transcription Factor 4 and C/EBP homologous protein was lower in baicalein group compared with CPR group. ROS in tunicamycin group was higher than in CPR group. And ROS in baicalein +tunicamycin group was lower than in tunicamycin group. Conclusion: Ferroptosis and ER stress are both involved in brain injury after ROSC. Baicalein alleviates brain injury via suppressing the ferroptosis and ER stress, and reduces ROS partly through inhibiting ER stress. Baicalein is a potential drug to relieve brain injury after ROSC.
参考来源
- Ye Z, Zhang F, Wang P, et al. BAICALEIN RELIEVES BRAIN INJURY VIA INHIBITING FERROPTOSIS AND ENDOPLASMIC RETICULUM STRESS IN A RAT MODEL OF CARDIAC ARREST. Shock. 2022. PMID: 36427096. doi:10.1097/SHK.0000000000002058
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。